CG Oncology

Biotech · Public

Cretostimogene oncolytic adenovirus (intravesical immunotherapy for bladder cancer)

cgoncology.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
21
5 granted · 16 pending
Sector median: 2

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2878SPECTRAL THERAPEUTICS, INC.——
2879CYPRESS BIOPHARMA, INC.——
2880Sophia Bioscience Inc——
2881CG Oncology——
2882LABORECOM THERAPEUTICS INC.——
2883BIOCOGNON LLC——
2884MYOLOGICA, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 5 granted of 21

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.